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A retrospective analysis of ketamine administration by 
Critical Care Paramedics in a pre-hospital care setting 
 
ABSTRACT 
Objective: This project aims to describe pre-hospital use of Ketamine in trauma by South 
East Coast Ambulance Service Critical Care Paramedics and evaluate the occurrence of any 
side effects or adverse events. 
Methods: A retrospective analysis of patients receiving pre-hospital ketamine for trauma 
between 16th March 2013 and 30th April 2017. Administrations were identified from 
Advanced Life Saving Intervention and Procedure reports submitted by the clinician and, 
later, from an electronic database. Each was scrutinised for patient demographics, doses 
and reports of side effects or adverse events. 
Results: 510 unique administrations were identified. Following the exclusion of 61 records 
449 (88.0%) administrations remained. The most common indication for administration of 
ketamine was lower limb injury, with 228 (50.8%) administrations. Ketamine was only 
administered intravenously, and the median dose of ketamine for all administrations was 
30mg (IQR, 20–40 mg). The gender split was dominated by males who accounted for 302 
(67.3%) of administrations compared to 147 (32.7%) females. The median age of patients 
was 44 years (interquartile range, IQR 28–58 years) with women on average being older 
than men. Telephone calls to a consultant were made for 243/449 (54.1%) of the 
administrations, reflecting a need for sanctioning of the drug, advice on dosages or 
indications, for example.  
Conclusions: Critical Care Paramedics within a well governed system are able to safely 
administer ketamine within an approved dosing regimen under a Patient Group Direction. 
Median doses are in keeping with nationally approved guidelines. Reported side effects 
were within the described frequencies in the British National Formulary. Prospective studies 
are now needed in order to confirm the safety and efficacy of ketamine administration 
amongst the advanced Paramedic population 
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INTRODUCTION 
In the national and international pre-hospital setting, ketamine has been used for many 
years, both in military and civilian medicine. While ketamine has been successfully 
administered by paramedics in the UK out-of-hospital setting, there is very little information 
available regarding paramedic use, and is far less widely reported when compared to 
physicians (McQueen et al., 2014). Ketamine is not listed in Schedule 17 of the Human 
Medications Regulations 2012 and as such it is only used by paramedics under a Patient 
Group Direction (PGD).  Some specialist paramedics, have locally written PGDs and Clinical 
Management Plans (CMPs) which allow the administration of ketamine (McQueen et al., 
2014; von-Vopelius-Feldt & Benger, 2014). However, nationally, many of these normally 
operate within, or are aligned to, an air ambulance service.  
South East Coast Ambulance Service NHS Foundation Trust (SECAmb) has developed a 
Critical Care programme, comprised of experienced paramedics (minimum 3 years post 
registration) who undertake a further year of Level 7 postgraduate study, obtaining a 
Postgraduate Certificate in Patient Assessment and Management (Critical Care). In addition, 
an enhanced governance system and 24-hour consultant physician support, has permitted 
the administration of ketamine under a PGD (Table 1). 
There are currently nine CCP team teams distributed across the Trust’s geographical area. 
Each geographical team comprises seven CCPs, including two Practice Leads. Each of the 
seven CCPs are allocated to one of seven ‘horizontal’ teams that meets every 7 weeks for a 
period of shared governance and skills assurance training. This governance time is 
paramount to ensure patient safety as it allows for a high level of oversight, combined with 
revalidation training, uplift of new skills and a platform for continued professional 
development. Each of these sessions is overseen by a CCP Practice Lead. 
Within SECAmb, ketamine is administered as an analgesic, forming part of a multi-modal 
analgesia approach, and as a procedural sedative in the case of traumatic injury and the 
management of agitated head injuries. It is also indicated as a sedative where there is a 
need for transcutaneous pacing or cardioversion, though these latter two indications have 
not been included in this evaluation. The PGD itself is lengthy, and can’t be included here, 
but a brief summary of the main points is shown in Table 1. Note that, unlike many 
international paramedic programmes, ketamine is not currently administered within 
SECAmb for any kind of acute behavioural disturbance outside the context of traumatic 
head injury.  
Ketamine is only administered by CCPs in SECAmb. In the first year of a CCP’s practice, 
ketamine can only be administered following a consultant phone call. If, after this year, 
competence can be proven both theoretically and in practice, then autonomous 
administration can commence.  
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Table 1: Basic summary of PGD 
Indications (Analgesia) 
Management of Moderate to Severe Pain 
 
Indications (Sedation) 
Life or limb threating conditions that require 
sedation for emergency care. 
Management of the undifferentiated cerebrally 
agitated trauma patient. 
Inclusion Criteria (Analgesia) 
Adults & Children 12 years and above who are in 
traumatic pain and other analgesia contraindicated 
or have failed to control the pain or the patient has 
life/limb threatening injuries and the pain is 
preventing emergency treatment 
Inclusion Criteria (Sedation) 
Adults and children over 12 years of age who 
require analgesia and sedation to facilitate a life or 
limb saving intervention such as fracture reduction 
Or 
Adults and children over 12 years of age who are 
combative and unmanageable due to cerebral 
agitation after suffering undifferentiated trauma. 
Another trained pre-hospital care provider 
competent in airway management must be present 
at scene. 
Exclusion Criteria 
Known allergy to ketamine or excipients, where 
essential monitoring (including EtCO2) is not 
possible, known concurrent theophylline 
administration; significant hypertension, severe 
coronary/myocardial disease, severe CVS disease, 
raised ICP, raised IOP, known history of psychosis, 
pre-eclampsia, eclampsia, acute porphyria, 
intracranial mass lesions, hydrocephalus. 
Dosing (Analgesia) 
Initial bolus dose of 0.1mg/kg; repeat doses of 
0.1mg/kg by titration to achieve intended analgesic 
effect. For practical purposes: 
 Small adult: (40kg – 70kg): 5mg aliquots 
 Large adult (≥70kgs) 10mg aliquots 
Pain must be reassessed between doses. 
To a maximum dose of 0.5mg/kg in 30 minutes. 
Dosing (Sedation) 
Initial bolus dose of 0.1 – 0.2mg/ kg repeated by 0.1 
– 0.2mg/kg per minute by titration to achieve 
intended sedative effect. For practical purposes: 
small adult: (40kg – 70kg): 5mg aliquots; Large adult 
(≥70kgs) 10mg aliquots. 
To a maximum dose of 0.5mg/kg in 30 minutes. 
NB: In order to exceed the maximum dose, a consultant telephone call must be made 
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METHODS 
Setting 
SECAmb is an urban, suburban and rural NHS funded ambulance service that broadly 
encompasses the counties of Sussex, Surrey and Kent, and receives nearly 862,000 calls 
each year (South East Coast Ambulance Service NHS Foundation Trust, 2017). It employs 
2700 clinical staff of which 60 (2.2%) were operating as CCPs as of 30th April 2017. 
Patient Selection 
All patients receiving ketamine for a traumatic aetiology, who had ketamine administered 
by a CCP, and who had a completed record on the CCP registry of Advanced Life Saving 
Interventions and Procedures (ALSIP), or on CCPBase, between the 16th March 2013 and the 
30th April 2017 were included. A complete record includes: date of incident, patient age, 
indication for administration and dose administered. Records were excluded if 
administration was for a medical aetiology, the ALSIP was incomplete or ketamine was 
administered by a non-CCP (e.g. a doctor employed by the trust). All included entries were 
reviewed for side effects and adverse events that occurred during/after administration, 
while the patient was still in the care of the CCP. 
  
Statistical Analysis 
The data was collated in Microsoft Excel (2010) and analysed using R 3.3.3 (R Core Team 
2017). Following anonymisation of the data (both patient and CCP), descriptive statistics 
were generated. It was not possible to capture the precise dosing regimen (weight, intervals 
etc) as this was not part of the original data set. 
 
RESULTS 
A total of 510 unique administrations were identified. Following the exclusion of 61 records 
(Table 2), 449 (88.0%) administrations remained for inclusion. The most common indication 
for administration of ketamine was lower limb injury, with 228 (50.8%) administrations 
(Figure 1 and Table 3). All ketamine was administered intravenously, and the median dose 
of ketamine for all administrations was 30mg (IQR, 20–40 mg). The gender split was 
dominated by males who accounted for 302 (67.3%) of administrations compared to 147 
(32.7%) females (Figure 2). This is in keeping with the most recent trauma epidemiology 
statistics for the UK (Kehoe et al., 2015). The median age of patients was 44 (interquartile 
range, IQR 28–58) with women on average being older (median 53, IQR 31–75) than men 
(median 40, IQR 26–54). Telephone calls to a consultant were made for 243/449 (54.1%) of 
the administrations, reflecting a need for sanctioning of the drug, advice on dosages or 
indications, for example.  
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Table 2: Excluded records with rationale 
Exclusion rationale Number 
Non-traumatic aetiology 27 
No complete ALSIP 23 
Ketamine drawn up but not administered 8 
Ketamine not administered by CCP 1  
Duplicate entry 2 
Total 61 
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Table 3: Basic summary table 
Indication n 
Median 
total dose 
(mg) 
Interquartile 
range total dose 
(mg) 
Min 
total 
dose 
(mg) 
Max 
total 
dose 
(mg) Male Female 
Median 
age 
(years) 
IQR age 
(years) 
Min age 
(years) 
Max age 
(years) 
lower limb 
injury 
228 30 20-40 5 90 153 75 44 25-61.5 7 96 
polytrauma 82 30 20-40 10 80 59 23 40 28-53 18 86 
upper limb 
injury 
46 30 20-40 5 80 27 19 46 33-60 17 91 
other 40 20 10-30 5 180 24 16 44 38.5-
57.5 
20 88 
sedation 28 22.5 20-35 10 90 23 5 52 25.5-
64.5 
16 85 
spinal injury 16 22.5 17.5-37.5 10 60 9 7 46 33.5-51 20 78 
burns 9 50 40-70 10 80 7 2 32 30-40 26 47 
Total 449 30 20-40 5 180 302 147 44 28-58 7 96 
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Side Effects and Adverse Events 
Side effects or adverse events were noted in 16/449 (3.6%) of the administrations (Table 4). 
All of the side effects are in line with the expectancy of known side effects for ketamine 
analgesia and sedation (Joint Formulary Committee, 2017). No harm was reported in any of 
the events, and each record documented how the incident was managed by the CCP. This 
typically involved simple airway manoeuvres, including a period of bag-valve-mask 
ventilation. Vomiting was not reported in any patient that could not clear their own airway.  
Table 4: Side effects and adverse incidents as a result of ketamine administration by CCP 
Side effects n Median 
total dose 
(mg) 
Interquartile 
range (mg) 
Minimum 
total dose 
(mg) 
Maximum 
total dose 
(mg) 
Transient blood 
pressure increase 
6 30 20-40 15 50 
Respiratory 
depression 
3 30 25-35 20 40 
Vomiting 3 25 22.5-32.5 20 40 
Mild emergence 
phenomena 
2 25 20-30 20 30 
Distressed 1 30 30-30 30 30 
Adverse events      
Accidental OD 1 180 180-180 180 180 
Total 16 30 20-40 15 180 
 
DISCUSSION 
As far as we are aware, this is the largest published evaluation of out-of-hospital ketamine 
administration by paramedics. The demographic in this case shows a higher median age, 
and larger proportion of men than most other comparable studies (Porter, 2004; Bredmose 
et al., 2009; Johansson et al., 2009, Figures 1 and 2). Hollis et al. (2017) reported a similar 
age range profile, though again, a higher proportion of women. The reasons for the 
different demographics here is not known but is likely to reflect the different pre-hospital 
environments, and the demographics of the local population. The median therapeutic dose 
is similar to one study (Johansson et al., 2009) though the qualification of administering 
clinician in that case is unclear. Other studies report a larger mean dose (Porter, 2004; 
Bredmose et al., 2009), though they are entirely physician delivered. Hollis et al. (2017) 
describes Paramedic administration but does include a mix of IV/IM administration and a 
number of patients sedated for acute behavioural disturbance. The only other UK based 
Paramedic articles do not mention mean dose (McQueen et al., 2014; Edwards et al., 2016).  
One point of note is that the total doses used in sedation are no different to those used in 
analgesia. Whilst the PGD recommends a broadly similar dosing regimen for both, intuitively 
a sedation indication would involve a higher total dose than in analgesia. The most likely 
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explanation for this is that patients that needed sedating are far likelier to have had their 
care passed to a Helicopter Emergency Medicine Service (HEMS), and so the total dose given 
by the CCP would appear relatively low in comparison to those patients who remained with 
the CCP for their entire prehospital phase. 
Regarding the site of injury, the results also show that isolated limb injuries were by far the 
most common indication for ketamine analgesia, and considering Lee and Porter’s (2005) 
discussion around how common this type of injury is in pre-hospital care, and the need for 
early fracture reduction, this is unsurprising. 
Side effects 
Side effects are reported in most other studies (Porter, 2004; Svenson & Abernathy, 2007; 
Bredmose et al., 2009; Galinski et al., 2007; Johansson et al., 2009; Edwards et al., 2016) but 
sample numbers are too low to draw conclusions. Svenson & Abernathy (2007), Porter 
(2004) and Edwards et al (2016) report no adverse effects whilst Bredmose et al (2009) 
reported a similar proportion to this project. None of these categorised adverse events in 
the same way, but the proportions observed here are within the range reported in the BNF 
(Joint Formulary Committee, 2017). No other study reported a medication error but, again, 
no other study has such a large population size. It should be noted that, even at the size of 
this population, the frequency of reported side effects was low. 
When examining the side effects seen in this evaluation with the context of those stated in 
the BNF (Joint Formulary Committee, 2017), all except respiratory depression fall in to the 
common or very common category (defined as occurring in 1:100 [1%] to 1:10 [10%] of patients) 
with respiratory depression occurring rarely (1:1000 [0.1%] to 1:100 [1%]). If we take the halfway 
points of these groups (i.e. 5% and 0.5%) then the number needed to harm can be calculated as 35.7 
patients for the common to very common side effects and 1000 patients for the rare side effects. 
The side effects that occurred in this evaluation, while causing no harm to the patient, have 
the potential to cause complications if not managed correctly. It seems prudent that 
ketamine continues to be administered only by specialist Paramedics, who have received 
additional, specific training in identifying and managing side effects from the drug, in 
keeping with the Academy of Medical Royal Colleges (2013) recommendations.  
Ketamine use within SECAmb has increased year on year, though this is likely to be due both 
to an increasing scope of practice and numbers of CCPs. The increase may also be due, in 
part, to improved familiarity with the drug and confidence to administer.  
Looking to the future, there may be a role for ketamine use in acute behavioural 
disturbance, an indication that is commonplace in other parts of the world, and was an 
indication in the Hollis et al. (2017) study.  
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Figure 1: Simple bar chart showing patient counts for each indication, stratified by gender 
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Figure 2: Histogram, comparing age with patient counts. Fill colour indicates indication. 
 
 
Strengths and limitations 
This was a retrospective analysis, strengthened most by its large patient population in 
comparison to other studies of Paramedic administered ketamine. However, care must be 
taken in generalising these results to other clinical areas, trusts or patient populations, but it 
should serve as a base for further prospective studies and service development. 
Side effects and adverse events did not have a formal method of being recorded, other than 
in the free text of the report or patient record. Consequently, there is a possibility that side 
effects or adverse events occurred but were not documented. CCPs are mandated to 
10 
 
document any side effects or adverse events, so it is probable that the number of 
undeclared side effects is low. All CCPs were made aware of the intended study, prior to 
data collection, so they could retrospectively enter any adverse effects that hadn’t been 
previously noted, though the authors accept the limitations here that people may not 
sufficiently recall incidents that are in the past or could have edited them to appear more 
favourable. Other interventions and therapies were not gathered as part of this analysis. 
Patients are likely to have received other analgesics, such as morphine which may bias the 
dose and side effect profile. The use of anti-emetics is also not recorded within this analysis. 
Since methods and detail of data collection changed over the years, interrogation of all 
entries took place but it wasn’t always clear whether the administration was for analgesia or 
sedation. Clearly this is another limitation of the study, and future analysis should be clear 
to separate the two as the dosing regimen is likely to be different. 
CONCLUSION 
Ketamine has been administered over 500 times by CCPs operating within South East Coast 
Ambulance Service NHS Trust area. In the largest retrospective analysis of its kind, and one 
of very few focussing on Paramedic only administration, levels of side effects and adverse 
events are in line with nationally documented expectations. Patient demographics show an 
increased age when compared with other studies, and a larger proportion of males. These 
statistics are in line with epidemiological studies in traumatology, and is likely to reflect the 
traumatic nature of the indications for use, and the older demographic of the geographical 
region in which the CCPs operate.  
This evaluation provides a useful platform for increasing the evidence base for Paramedic 
administered ketamine. However, prospective studies are now needed in order to confirm 
the safety and efficacy of ketamine administration amongst the advanced Paramedic 
population 
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